Anika Therapeutics (ANIK) Return on Capital Employed Growth (5y) (2016 - 2026)
Anika Therapeutics (ANIK) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Anika Therapeutics | 286.46 Mn | 248.05 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 159.00 |
| Mar 31, 2026 | 330.00 |
| Dec 31, 2025 | 142.00 |
| Sep 30, 2025 | -592.00 |
| Jun 30, 2025 | -902.00 |
| Mar 31, 2025 | -1,444.00 |
| Dec 31, 2024 | -1,372.00 |
| Sep 30, 2024 | -425.00 |
| Jun 30, 2024 | -710.00 |
| Mar 31, 2024 | -791.00 |
| Dec 31, 2023 | -796.00 |
| Sep 30, 2023 | -1,090.00 |
| Jun 30, 2023 | -1,072.00 |
| Mar 31, 2023 | -1,279.00 |
| Dec 31, 2022 | -1,612.00 |
| Sep 30, 2022 | -2,567.00 |
| Jun 30, 2022 | -2,612.00 |
| Mar 31, 2022 | -2,120.00 |
| Dec 31, 2021 | -2,149.00 |
| Sep 30, 2021 | -2,694.00 |